ADCT-701 targets DLK1 on the cell surface; after internalization, cathepsin cleavage releases a PBD payload that binds the DNA minor groove and forms interstrand cross-links, killing DLK1-positive cells. DNA is the intracellular payload target, not the directly targeted antigen.